Expert Opinion on Drug Safety, Volume 21, Issue 5 (2022)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Drug Safety, Volume 21, Issue 5 (2022)

See all volumes and issues
Vol 23, 2024 Vol 22, 2023 Volume 21, 2022 Vol 20, 2021 Vol 19, 2020 Vol 18, 2019 Vol 17, 2018 Vol 16, 2017 Vol 15, 2016 Vol 14, 2015 Vol 13, 2014 Vol 12, 2013 Vol 11, 2012 Vol 10, 2011 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002
Download citations Download PDFs Download issue

Editorial

Editorial
Pharmacovigilance approaches to study rare and very rare side-effects: the example of clozapine-related DiHS/DRESS syndrome
Renato de Filippis, Pasquale De Fazio, John M. Kane & Georgios Schoretsanitis
Pages: 585-587
Published online: 18 Apr 2022
First Page PreviewforPharmacovigilance approaches to study rare and very rare side-effects: the example of clozapine-related DiHS/DRESS syndrome | Full Text | References | PDF (143.6 KB) | EPUB
  • 1834 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access

Review

Safety and efficacy review of aflibercept for the treatment of metastatic colorectal cancer
David K. Lau, Justin Mencel & Ian Chau
Pages: 589-597
Published online: 05 Jan 2022
AbstractforSafety and efficacy review of aflibercept for the treatment of metastatic colorectal cancer | Full Text | References | PDF (339.1 KB) | EPUB
  • 236 Views
  • 1 CrossRef citations
  • 0Altmetric
Nobel Prize for immune checkpoint inhibitors, understanding the immunological switching between immunosuppression and autoimmunity
Ion G. Motofei
Pages: 599-612
Published online: 27 Dec 2021
AbstractforNobel Prize for immune checkpoint inhibitors, understanding the immunological switching between immunosuppression and autoimmunity | Full Text | References | PDF (807.8 KB) | EPUB
  • 270 Views
  • 0 CrossRef citations
  • 0Altmetric
Tailored first-line biologic and targeted synthetic disease modifying anti-rheumatic drugs therapy in patients with rheumatoid arthritis: 2021 updated ITABIO statements
Fabrizio Cantini, Delia Goletti, Maurizio Benucci, Rosario Foti, Arianna Damiani & Laura Niccoli
Pages: 613-623
Published online: 29 Dec 2021
AbstractforTailored first-line biologic and targeted synthetic disease modifying anti-rheumatic drugs therapy in patients with rheumatoid arthritis: 2021 updated ITABIO statements | Full Text | References | PDF (836.2 KB) | EPUB
  • 374 Views
  • 1 CrossRef citations
  • 0Altmetric
Does the gut microbiome mediate antipsychotic-induced metabolic side effects in schizophrenia?
Svetlina S. Vasileva, Jack Tucker, Dan Siskind & Darryl Eyles
Pages: 625-639
Published online: 28 Feb 2022
AbstractforDoes the gut microbiome mediate antipsychotic-induced metabolic side effects in schizophrenia? | Full Text | References | PDF (2.7 MB) | EPUB
  • 506 Views
  • 1 CrossRef citations
  • 0Altmetric
Cardiac adverse effects of antiseizure medications
Gaetano Zaccara, Simona Lattanzi & Francesco Brigo
Pages: 641-652
Published online: 29 Dec 2021
AbstractforCardiac adverse effects of antiseizure medications | Full Text | References | PDF (652.4 KB) | EPUB
  • 415 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Safety considerations with the current treatments for peripheral T-cell lymphoma
Tarsheen Sethi, Francesca Montanari & Francine Foss
Pages: 653-660
Published online: 06 Feb 2022
AbstractforSafety considerations with the current treatments for peripheral T-cell lymphoma | Full Text | References | PDF (314.8 KB) | EPUB
  • 285 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Anti-inflammatory strategies for atherosclerotic artery disease
Federica Agnello & Davide Capodanno
Pages: 661-672
Published online: 02 Mar 2022
AbstractforAnti-inflammatory strategies for atherosclerotic artery disease | Full Text | References | PDF (2.1 MB) | EPUB
  • 269 Views
  • 1 CrossRef citations
  • 0Altmetric
Vortioxetine in major depressive disorder: from mechanisms of action to clinical studies. An updated review
Javier De Diego-Adeliño, José Manuel Crespo, Fernando Mora, Adrián Neyra, Pedro Iborra, Luis Gutiérrez-Rojas & Selman F. Salonia
Pages: 673-690
Published online: 29 Dec 2021
AbstractforVortioxetine in major depressive disorder: from mechanisms of action to clinical studies. An updated review | Full Text | References | PDF (688.2 KB) | EPUB
  • 15349 Views
  • 8 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
Safety and effectiveness of ramucirumab and docetaxel: a single-arm, prospective, multicenter, non-interventional, observational, post-marketing safety study of NSCLC in Japan
Yucherng Chen, Soshi Nagaoka, Taeko Katayose & Nobuyuki Sekine
Pages: 691-698
Published online: 24 Jan 2022
AbstractforSafety and effectiveness of ramucirumab and docetaxel: a single-arm, prospective, multicenter, non-interventional, observational, post-marketing safety study of NSCLC in Japan | Full Text | References | PDF (559.4 KB) | EPUB | Supplemental
  • 679 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Barriers and facilitators for systematically registering adverse drug reactions in electronic health records: a qualitative study with Dutch healthcare professionals
Isa P. A. C. Geeven, Naomi T. Jessurun, Arthur T. M. Wasylewicz, Marjolein Drent, Phyllis I. Spuls, Frank Hoentjen, Eugène P. van Puijenbroek, Harald E. Vonkeman, Koen P. Grootens, Martijn B. A. van Doorn, Bart J. F. van Den Bemt & Charlotte L. Bekker
Pages: 699-706
Published online: 24 Jan 2022
AbstractforBarriers and facilitators for systematically registering adverse drug reactions in electronic health records: a qualitative study with Dutch healthcare professionals | Full Text | References | PDF (1.1 MB) | EPUB
  • 2482 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Article
Proton pump inhibitors and increased reporting odds of renal neoplasms: FAERS-based adverse event data mining and analysis
Weijuan Song, Lei Shi, Yanhong Wang & Zisen Zhang
Pages: 707-713
Published online: 29 Dec 2021
AbstractforProton pump inhibitors and increased reporting odds of renal neoplasms: FAERS-based adverse event data mining and analysis | Full Text | References | PDF (609.4 KB) | EPUB | Supplemental
  • 310 Views
  • 1 CrossRef citations
  • 0Altmetric

Explore articles